Literature DB >> 33479243

Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primate.

Erika Coletto1, Iain R Tough2, Sara Pritchard3, Atsuko Hikima1, Michael J Jackson1, Peter Jenner1, K Ray Chaudhuri4,5, Helen M Cox2, Mahmoud M Iravani6, Sarah Rose7.   

Abstract

The pathological changes underlying gastrointestinal (GI) dysfunction in Parkinson's disease (PD) are poorly understood and the symptoms remain inadequately treated. In this study we compared the functional and neurochemical changes in the enteric nervous system in the colon of adult, L-DOPA-responsive, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmoset, with naïve controls. Measurement of mucosal vectorial ion transport, spontaneous longitudinal smooth muscle activity and immunohistochemical assessment of intrinsic innervation were each performed in discrete colonic regions of naïve and MPTP-treated marmosets. The basal short circuit current (Isc) was lower in MPTP-treated colonic mucosa while mucosal resistance was unchanged. There was no difference in basal cholinergic tone, however, there was an increased excitatory cholinergic response in MPTP-treated tissues when NOS was blocked with L-Nω-nitroarginine. The amplitude and frequency of spontaneous contractions in longitudinal smooth muscle as well as carbachol-evoked post-junctional contractile responses were unaltered, despite a decrease in choline acetyltransferase and an increase in the vasoactive intestinal polypeptide neuron numbers per ganglion in the proximal colon. There was a low-level inflammation in the proximal but not the distal colon accompanied by a change in α-synuclein immunoreactivity. This study suggests that MPTP treatment produces long-term alterations in colonic mucosal function associated with amplified muscarinic mucosal activity but decreased cholinergic innervation in myenteric plexi and increased nitrergic enteric neurotransmission. This suggests that long-term changes in either central or peripheral dopaminergic neurotransmission may lead to adaptive changes in colonic function resulting in alterations in ion transport across mucosal epithelia that may result in GI dysfunction in PD.

Entities:  

Year:  2021        PMID: 33479243      PMCID: PMC7820491          DOI: 10.1038/s41531-020-00150-x

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  47 in total

Review 1.  How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology.

Authors:  Per Borghammer
Journal:  Mov Disord       Date:  2017-08-26       Impact factor: 10.338

2.  Colonic inflammation in Parkinson's disease.

Authors:  David Devos; Thibaud Lebouvier; Bernard Lardeux; Mandy Biraud; Tiphaine Rouaud; Hélène Pouclet; Emmanuel Coron; Stanislas Bruley des Varannes; Philippe Naveilhan; Jean-Michel Nguyen; Michel Neunlist; Pascal Derkinderen
Journal:  Neurobiol Dis       Date:  2012-09-24       Impact factor: 5.996

3.  The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.

Authors:  Niall P Hyland; Helen M Cox
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease.

Authors:  Gennaro Pagano; Echo E Tan; Janelle M Haider; Alyssa Bautista; Michele Tagliati
Journal:  Parkinsonism Relat Disord       Date:  2014-11-25       Impact factor: 4.891

5.  Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease.

Authors:  Grant Anderson; Ali Reza Noorian; Georgia Taylor; Mallappa Anitha; Doug Bernhard; Shanthi Srinivasan; James G Greene
Journal:  Exp Neurol       Date:  2007-05-18       Impact factor: 5.330

6.  Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms.

Authors:  Maria G Cersosimo; Gabriela B Raina; Cristina Pecci; Alejandro Pellene; Cristian R Calandra; Cristiam Gutiérrez; Federico E Micheli; Eduardo E Benarroch
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

7.  Signaling of free fatty acid receptors 2 and 3 differs in colonic mucosa following selective agonism or coagonism by luminal propionate.

Authors:  Iain R Tough; Sarah Forbes; Helen M Cox
Journal:  Neurogastroenterol Motil       Date:  2018-08-23       Impact factor: 3.598

8.  Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates.

Authors:  Henry Resnikoff; Jeanette M Metzger; Mary Lopez; Viktoriya Bondarenko; Andres Mejia; Heather A Simmons; Marina E Emborg
Journal:  J Inflamm Res       Date:  2019-05-07

9.  Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease.

Authors:  Erika Coletto; John S Dolan; Sara Pritchard; Alex Gant; Atsuko Hikima; Michael J Jackson; Christopher D Benham; K Ray Chaudhuri; Sarah Rose; Peter Jenner; Mahmoud M Iravani
Journal:  NPJ Parkinsons Dis       Date:  2019-06-10

10.  Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndrome.

Authors:  Lina Basel-Vanagaite; Bruno Dallapiccola; Ramiro Ramirez-Solis; Alexandra Segref; Holger Thiele; Andrew Edwards; Mark J Arends; Xavier Miró; Jacqueline K White; Julie Désir; Marc Abramowicz; Maria Lisa Dentici; Francesca Lepri; Kay Hofmann; Adi Har-Zahav; Edward Ryder; Natasha A Karp; Jeanne Estabel; Anna-Karin B Gerdin; Christine Podrini; Neil J Ingham; Janine Altmüller; Gudrun Nürnberg; Peter Frommolt; Sonia Abdelhak; Metsada Pasmanik-Chor; Osnat Konen; Richard I Kelley; Mordechai Shohat; Peter Nürnberg; Jonathan Flint; Karen P Steel; Thorsten Hoppe; Christian Kubisch; David J Adams; Guntram Borck
Journal:  Am J Hum Genet       Date:  2012-11-29       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.